- 29 Jul 2017 Allan Bradley at Canaccord Genuity Growth Conference
- 9 Jan 2017 Kymab expands Infectious Disease Programmes
- 24 Nov 2016 Kymab secures US$100 million Series C funding
- 6 May 2015 Kymab secures US$90 million funding
- 16 May 2014 Gates and Wellcome Trust invest in Kymab
- 12 Jul 2010 Wellcome Trust £20 million financing agreement
We use cookies on our website. Carry on browsing if you’re happy with this or find out more
Featured article: Kymab Announces Presentations at the 24th EHA Annual Congress
Two Company-sponsored oral and poster abstracts to be presented on KY1049 and IntelliSelect® Bispecifics platform
Read article
Featured article: Kymab Poster on Adaptive Phase 1/2 Clinical Trial for KY1044 anti-ICOS Program at 2019 ASCO Meeting
Clinical trial initiated in February 2019 in the U.S., MD Anderson Cancer Center and Sarah Cannon Research Institute Phase ...
Read article